Literature DB >> 8807194

Protein tyrosine kinase inhibitors act downstream of IL-1 alpha and LPS stimulated MAP-kinase phosphorylation to inhibit expression of E-selectin on human umbilical vein endothelial cells.

P Adamson1, M Tighe, J D Pearson.   

Abstract

HUVEC exposed to IL-1 alpha, TNF alpha or LPS showed a time dependent increase in E-selectin expression which was maximal at between 4-6h after stimulation. Stimulation of HUVEC with IL-1 alpha, TNF alpha or LPS for between 2 and 6h followed by removal or neutralisation of IL-1 alpha, TNF alpha or LPS and incubation in new media up to 6h resulted in identical levels of E-selectin expression at 6h, as cells which had been continuously stimulated for 6h with IL-1 alpha, TNF alpha or LPS. These studies demonstrated that HUVEC were committed to the induction of E-selectin following a 2 hr incubation with either IL-1 alpha, TNF alpha or LPS. The protein tyrosine kinase (PTK) inhibitors ST271, ST638 or genistein (0-100M) were ineffective in reducing cytokine or LPS stimulated E-selectin expression during a 2h cytokine or LPS stimulation of cells, in which inhibitors were either coincubated with cytokine/LPS or previously preincubated with the PTK inhibitors. However when PTK inhibitors were present during both agonist activation (2h) and subsequent expression of E-selectin after removal of agonist (4h) the PTK inhibitors resulted in a dose dependent reduction in both IL-1 alpha and LPS stimulated E-selectin expression (IC50 = 50M). Moreover when PTK inhibitors were only incubated with cells for the 4h after cytokine or LPS activation of cells, PTK inhibitors resulted in a more effective dose dependent reduction in IL-1 alpha or LPS stimulated E-selectin expression (IC50 = 10M). Determination of total and surface expressed E-selectin showed that the reduction in E-selectin expression represented a reduction in E-selectin protein and analysis of E-selectin mRNA by RT-PCR demonstrated that inhibition of E-selectin protein synthesis reflected reduced E-selectin mRNA. Other cytokine or LPS signalling pathways such as the activation of MAP-kinase (ERK-2) was unaffected by pre and coincubation with the PTK inhibitors. These studies suggest that HUVEC can become committed to the induction of E-selectin after removal of the stimulus and that protein tyrosine kinase inhibitors do not effect initial (5-30 min) cytokine or LPS signals which result in E-selectin expression but can inhibit the expression of cytokine/LPS induced E-selectin expression at a step distal to MAP-kinase activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807194     DOI: 10.3109/15419069609081027

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  4 in total

1.  Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides.

Authors:  M Blank; Y Shoenfeld; S Cabilly; Y Heldman; M Fridkin; E Katchalski-Katzir
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Comparative effect of genistein and daidzein on the expression of MCP-1, eNOS, and cell adhesion molecules in TNF-α-stimulated HUVECs.

Authors:  Hye Yeon Cho; Chung Mu Park; Mi Jeong Kim; Radnaabazar Chinzorig; Chung Won Cho; Young Sun Song
Journal:  Nutr Res Pract       Date:  2011-10-28       Impact factor: 1.926

3.  FAK and Pyk2 activity promote TNF-α and IL-1β-mediated pro-inflammatory gene expression and vascular inflammation.

Authors:  James M Murphy; Kyuho Jeong; Yelitza A R Rodriguez; Jung-Hyun Kim; Eun-Young Erin Ahn; Ssang-Taek Steve Lim
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

4.  Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy via Ameliorating Endothelial Activation.

Authors:  Yunshuo Chen; Ranran Li; Siqi Shang; Xuejiao Yang; Lei Li; Wenbo Wang; Yueying Wang
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.